【新股消息 | 岸迈生物拟港股上市 中国证监会要求补充说明本次发行上市前后是否持续符合外商投资准入政策要求等】智通财经APP获悉，9月5日，中国证监会公示《境外发行上市备案补充材料要求(2025年8月29日—2025年9月4日)》，证监会国际司共对12家企业出具补充材料要求。其中要求岸迈生物补充说明本次发行上市前后是否持续符合外商投资准入政策要求等。据港交所6月17日披露，岸迈生物科技有限公司向港交所主板递交上市申请，中信证券和招银国际为联席保荐人。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.